U.S. Orthopedics Makers Shift Production To China
This article was originally published in PharmAsia News
Executive Summary
U.S. production of medical devices, long considered unlikely to join the outsourcing move to Southeast Asia, now is migrating to China as firms see it as a good place to make wares. Two orthopedic companies in Indiana already have opened plants in the country and a third has one under construction. The three are Biomet, DePuy Orthopaedics and Paragon Medical. The shift is not just for devices sold in Asia; it also includes production of products for the U.S. market. (Click here for more
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.